{{Rsnum
|rsid=6830321
|Gene=ANXA5
|Chromosome=4
|position=121693600
|Orientation=plus
|GMAF=0.4839
|Gene_s=ANXA5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.2 | 48.2 | 20.5
| HCB | 14.6 | 36.5 | 48.9
| JPT | 4.4 | 31.0 | 64.6
| YRI | 64.6 | 30.6 | 4.8
| ASW | 63.2 | 31.6 | 5.3
| CHB | 14.6 | 36.5 | 48.9
| CHD | 8.3 | 39.4 | 52.3
| GIH | 17.8 | 50.5 | 31.7
| LWK | 77.3 | 20.0 | 2.7
| MEX | 19.6 | 46.4 | 33.9
| MKK | 77.6 | 22.4 | 0.0
| TSI | 36.3 | 46.1 | 17.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=22341596
|Title=Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}